Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FESILTY safely and effectively. See full prescribing information for FESILTY. FESILTY (fibrinogen, human - chmt), lyophilized powder for reconstitution, for intravenous useInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-other
FESILTY is indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, including hypo- or afibrinogenemia. Limitations of Use: FESILTY is not indicated for dysfibrinogenemia.
- generic_name
- fibrinogen, human-chmt
- brand_name
- water
- product_names
- fibrinogen, human-chmt, water
- ndc
- 13533-502, 13533-503, 13533-200, 13533-502-01, 13533-503-02, 13533-200-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en